ASHOK PATEL: Open Payments
NPI 1124091798 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,981 in 118 payments from 17 companies in 2025. Trend: 2023 $1,039 · 2024 $1,610 · 2025 $1,981
Food & beverage: $1,981
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $323 |
| Teva Pharmaceuticals USA, Inc. | 31 | $311 |
| ABBVIE INC. | 9 | $190 |
| Supernus Pharmaceuticals, Inc. | 13 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $163 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Noven Therapeutics, LLC | 7 | $136 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Janssen Pharmaceuticals, Inc | 5 | $112 |
| Axsome Therapeutics, Inc. | 3 | $86 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, Qelbree, TRINTELLIX, REXULTI, Xelstrym, COBENFY.
Industry payments across FL — which companies pay providers there.
